Yusuke Okuma
0000-0001-5743-0149
53 papers found
Refreshing results…
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis
Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and Oncologists
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations
Response to “Immune-mediated cholangitis: is it always nivolumab’s fault?”
Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer
Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinib
Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma
Osseous oligometastases from thymic carcinoma: a case report suggesting the effectiveness of palliative-intent radiotherapy treatment
Missing publications? Search for publications with a matching author name.